CURRENT CLINICAL TRIALS
Pioneering treatments and insights for better blood health
A Phase 1/2, Open Label, Multicenter Study to Evaluate the Efficacy and Safety of DRL-1801 in Patients with Relapsed and Refractory Multiple Myeloma (SWASTH)
An Open Label, Multicenter, Phase IV Study of Teclistamab to Evaluate its Safety in Indian Participants with Relapsed and Refractory Multiple Myeloma who have previously received at least 3 prior lines of therapy including an Immunomodulatory agent, a Proteasome Inhibitor and an Anti-CD38 antibody and have demonstrated disease progression on the last therapy
A Phase 4 Study of Venetoclax in Combination with Azacitidine in Indian Subjects with Newly Diagnosed Acute Myeloid Leukemia Who are Ineligible for Standard Induction Therapy
A Phase IV, Open Label, Study Evaluating the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab and CHP (R-CHP) in Previously Untreated Adult Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
About Us
Our Hematology Mission
We deliver cutting-edge hematology clinical trials with unwavering commitment to scientific rigor and patient safety, advancing healthcare through reliable research and valuable insights.
25+
Clinical Trials
100+
Patients Enrolled
5k+
Research Hours
Why Choose Us
The Science Behind Our Success
We combine scientific excellence with patient-centered approaches for breakthrough hematology research.
Scientific Rigor
Every trial follows strict protocols ensuring reliable, reproducible results.
Patient Safety
Comprehensive safeguards and monitoring protect participants throughout the research process.
Breakthrough Research
Contributing valuable insights that advance hematology treatments worldwide.
ONGOING TRIALS
Hematology Research Services
We specialize in clinical trials that push boundaries in blood disorder treatments and research.
Client Experiences
See what participants say about our trials
- ★
- ★
- ★
- ★
- ★
“The indianclinicaltrials team provided exceptional care throughout my participation. Their attention to detail and commitment to safety made me confident in contributing to such important research.”
- ★
- ★
- ★
- ★
- ★
“Participating in indianclinicaltrials’ research was a seamless experience. The staff was knowledgeable, compassionate, and kept me informed at every stage of the process.”
FAQ
Common Questions
Find answers to frequently asked questions about our hematology clinical trials and participation process.
Transform Blood Health Research
Be part of groundbreaking advances in hematology treatments